Department of Obstetrics and Gynecology, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Am J Obstet Gynecol. 2010 Jun;202(6):577.e1-8. doi: 10.1016/j.ajog.2009.11.042. Epub 2010 Jan 22.
The purpose of this study was to compare the effectiveness of laparoscopic ovarian diathermy (LOD) vs clomiphene citrate (CC) plus metformin in infertile patients with CC-resistant polycystic ovary syndrome (PCOS).
Fifty primary infertile patients with CC-resistant PCOS were assigned randomly to receive LOD followed by a 6-month observation (group A) or 6-cycle course of CC plus metformin (group B). Reproductive and safety outcomes were analyzed.
No significant difference between 2 groups in pregnancy (15/92 women [16.3%] vs 14/107 women [13.1%]; P = .521) and live-birth (13/92 women [14.1%] vs 12/107 women [11.2%]; P = .536) rates per cycle was observed. With the use of a Cox regression analysis, patients under medical treatment, compared with patients who received surgical treatment, had a relative risk of pregnancy of 1.2 (95% confidence interval, 0.61-2.44; P = .582) and a relative risk of live-birth of 1.4 (95% confidence interval, 0.63-2.96; P = .425).
LOD and CC plus metformin seem to be 2 effective approaches to treat infertility in patients with CC-resistant PCOS.
本研究旨在比较腹腔镜卵巢电灼术(LOD)与枸橼酸氯米酚(CC)加二甲双胍在 CC 抵抗型多囊卵巢综合征(PCOS)不孕患者中的疗效。
将 50 例 CC 抵抗型 PCOS 原发性不孕患者随机分为接受 LOD 后观察 6 个月(A 组)或接受 CC 加二甲双胍 6 个周期治疗(B 组)。分析生殖结局和安全性。
两组妊娠率(15/92 例女性[16.3%] vs 14/107 例女性[13.1%];P=0.521)和活产率(13/92 例女性[14.1%] vs 12/107 例女性[11.2%];P=0.536)差异无统计学意义。采用 Cox 回归分析,与接受手术治疗的患者相比,接受药物治疗的患者妊娠的相对风险为 1.2(95%置信区间,0.61-2.44;P=0.582),活产的相对风险为 1.4(95%置信区间,0.63-2.96;P=0.425)。
LOD 和 CC 加二甲双胍似乎是治疗 CC 抵抗型 PCOS 不孕患者的两种有效方法。